Marked Variation Seen in Care Quality for TIA, Minor Stroke

Share this content:
Marked Variation Seen in Care Quality for TIA, Minor Stroke
Marked Variation Seen in Care Quality for TIA, Minor Stroke

WEDNESDAY, Feb. 7, 2018 (HealthDay News) -- Care quality for patients with transient ischemic attack (TIA) or minor stroke varies substantially across elements of care and facilities, according to a study published online Feb. 5 in JAMA Neurology.

Dawn M. Bravata, M.D., from the Department of Veterans Affairs (VA) Health Services Research and Development Stroke Quality Enhancement Research Initiative in Washington, D.C., and colleagues examined the quality of guideline-recommended care for 8,201 patients with TIA or minor stroke receiving care in the Veterans Health Administration system during federal fiscal year 2014.

The researchers found that there was variation in performance across elements of care: brain imaging by day two (88.9 percent), antithrombotic use by day two (83.8 percent), hemoglobin A1c measurement by discharge or within the previous 120 days (82.5 percent), anticoagulation for atrial fibrillation by day seven after discharge (82.1 percent), deep vein thrombosis prophylaxis by day two (74.9 percent), hypertension control by 90 days after discharge (71.8 percent), neurology consultation by day one (70.6 percent), electrocardiography by day two or within one day prior (67 percent), carotid artery imaging by day two or within six months previously (64.1 percent), and moderate- to high-potency statin prescription by day seven after discharge (47.2 percent). Performance varied substantially across facilities, and higher performance was seen for admitted patients than for patients cared for only in the emergency departments.

"Health care systems should engage in ongoing TIA care performance assessment to complement existing stroke performance measurement," the authors write.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

NIH Panel Will No Longer Review Gene Therapy Experiments

NIH Panel Will No Longer Review Gene Therapy ...

FDA will now assess gene therapy experiments and products as it does with other treatments, drugs

Doctors Remove Contact Lens Embedded in Eyelid for Years

Doctors Remove Contact Lens Embedded in Eyelid for ...

Lens was encapsulated within the upper eyelid soft tissue since childhood eye trauma

CDC: Brucellosis in Dogs Remains a Public Health Risk

CDC: Brucellosis in Dogs Remains a Public Health ...

Infection is under-recognized, may remain a threat without stronger intervention measures

is free, fast, and customized just for you!




Already a member?

Sign In Now »